In this study, the IL-33 expression, in carcinoma cells, was positive in 49.43% (20.69% had high expression and 28.74% had low expression) while the VEGF expression was positive in 29.89% (6.90% had high expression and 22.99% had low expression). The gene discussed is IL33; the disease is carcinoma.